Home
Accretion Pharmaceuticals Ltd Board of Directors
From Blinkx's GPT
Key Highlights
- Mayur Popatlal Sojitra continues to serve as the Executive Director in 2024, maintaining the same position as in the previous year.
- Harshad Nanubhai Rathod continues to serve as the Director & CFO in 2024, maintaining the same position as in the previous year.
- Vivek Ashok Kumar Patel continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- Hardik Mukundbhai Prajapati continues to serve as the Executive Director in 2024, maintaining the same position as in the previous year.
- Shyam Bhadresh Kapadia. continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.

Accretion Pharmaceuticals Ltd
NSE: AccretionPha.
Share Price
Last Ten Days Market Price
Date | |
---|---|
23 May 2025 | 74.9 |
22 May 2025 | 78.8 |
21 May 2025 | 82.95 |
Company Fundamentals for Accretion Pharmaceuticals Ltd
Market Price of Accretion Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Accretion Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Accretion Pharmaceuticals Ltd News Hub
NSE SME Accretion Pharmaceuticals' IPO ends with subscription of 7.31 times
The initial public offer (IPO) of Accretion Pharmaceuticals received bids for 2,00,06,400 shares as
Read more
19 May 25
NSE SME Accretion Pharma stumbles on market debut
The scrip was listed at 79, a discount of 21.78% over the initial public offer (IPO) price. The stoc
Read more
21 May 25
Popular Search
FAQs for Board of Directors of null
How are members of Accretion Pharmaceuticals Ltd Board of Directors selected?
Members of the Accretion Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Accretion Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Accretion Pharmaceuticals Ltd Board of Directors?
Shareholders can interact with the Accretion Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Accretion Pharmaceuticals Ltd Board of Directors meet?
The Accretion Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Accretion Pharmaceuticals Ltd Board of Directors?
The Accretion Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Accretion Pharmaceuticals Ltd?
The current Board of Directors at Accretion Pharmaceuticals Ltd includes Mayur Popatlal Sojitra( Executive Director) ,Harshad Nanubhai Rathod( Director & CFO) ,Vivek Ashok Kumar Patel( Managing Director) ,Hardik Mukundbhai Prajapati( Executive Director) ,Shyam Bhadresh Kapadia.( Independent Director) . The full list can be found on Accretion Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.